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Gamete cryobanking has been widely incorporated in present assisted reproduc-
tive technology (ART). Preserving male gametes for future fertility is considered 
to be an easy and accessible way to insure one’s reproduction. Despite the fact that 
the method could not secure success, sperm freezing could be the only chance to 
father biological offspring. In cases when severe male factor (SMF) infertility is 
diagnosed (retrograde ejaculation, virtual azoospermia, obstructive azoospermia, 
cryptozoospermia) and providing fresh semen samples for assisted reproduction 
may alter chances to achieve pregnancy, rare sperm cryopreservation could contrib-
ute for conceiving. Isolation, selection and cryopreservation of single sperm cells 
from semen samples is a challenging procedure. Different approaches and devices 
could be used in order to extract utmost spermatozoa. Aiming to highest cryosur-
vival rates sperm freezing protocols should be carefully considered. For some men, 
rare sperm cryopreservation might be the only alternative for parenting biological 
offspring. Thus, the latter technique should be widely discussed, developed and 
practiced in assisted reproduction.
Keywords: cryopreservation, fertility preservation, single sperm selection,  
sperm sorting devices, cryptozoospermia, sperm genetics
1. Introduction
Gamete cryobanking has been considerably incorporated in present assisted 
reproductive technology (ART). Preserving fertility through banking is an acces-
sible and relatively reliable procedure that gives opportunity for men to parent their 
own biological child. Most of the clinics providing fertility treatment have their 
individual cryobanks and offer fertility preservation counseling. Network struc-
tures for gamete and tissue storage have also been developed. Some of the affirmed 
ones would be the Danish network (www.rigshospitalet.dk), FertiPROTECT ® 
(www.fertiprotect.com), German-Austrian-Swiss centralized and decentralized 
network between the countries, Oncofertility® Concortium (www.oncofertility.
northwestern.edu) for knowledge exchange in the field of fertility preservation [1]. 
The complexity of fertility preservation generates necessity for close interaction 
between the patients, reproductive specialist, reproductive biologist, urologist, 
oncologist, etc. In order to provide accurate and prompt counseling and treatment, 
each clinical case should be considered in full and timely.
Retrieving, freezing, storage and use of human oocytes, spermatozoa, embryos 
and ovarian and testicular tissue has been executively studied and explored in 
assisted reproduction (AR). Cryopreservation presents remarkable advance to men 
and women who have decided to postpone fertility. It turns out to be a safety plan 
for patient with subfertility and certain physiological or psychological conditions. 
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For patients with forthcoming cancer treatment it could be the only chance to have 
their own biological child.
Nowadays cryopreservation and cryobanking is inseparable branch to assisted 
reproduction and fertility preservation treatment.
2. Historical preview of sperm cryopreservation
First attempts to preserve human spermatozoa dates back to 1776 when Lazaro 
Spallanzani studied sperm cryopreservation by cooling it in snow. It was 1949 
when Polge, Smith and Parkes discovered glycerol to be effective in protecting 
spermatozoa exposed to low temperatures [2]. This discovery, alongside with the 
first reports for achieving pregnancy by frozen and thawed spermatozoa in 1953 by 
Dr. Jerome K. Sherman [3], led to constant development and improvement of sperm 
freezing protocols and devices. In 1972 a slow freezing protocol, developed by D. 
Whittingham, S. Leibo, and P. Mazur, was introduced. Slow cooling with tempera-
ture drops in the range of 0.3 to 2 degrees Celsius per minute and consequent slow 
warming (4 to 25 degrees C° per minute) was performed. This protocol, applied to 
mouse embryos, resulted in 65% pregnancy rate and 40% full term pregnancy [4]. 
Recent challenge in cryobiology was freezing spermatozoa from strains of geneti-
cally engineered mice. A novel method using a cryoprotectant composed of 18% 
raffinose pentahydrate and 3% skim milk was presented [5, 6].
Not only protecting sperm cells at low temperatures, but preserving their 
structural (morphological), kinetic and functional characteristics is at aim when 
freezing semen samples. It is well known that cryopreservation has deleterious 
effect on sperm cells.
Although spermatozoa are relatively small in size and have large surface, cold 
shock and ice formation could damage different cell structures and organelles, as 
most affected structures are the plasmalema, acrosome and the tail [7]. Changes 
in membrane organization and permeability, formation of reactive oxygen species 
(ROS) and consequent DNA damage as a result to freezing hinders normal sperm 
activity and functions [8].
Semen cryopreservation strives high quality of the preserved samples. Thus, 
retaining sperm motility and viability, membrane integrity and intact DNA in 
thawed samples, has been formed as priority when developing freezing protocols. 
Cryoprotective medium, containing various additives – fatty acids, proteins, 
antioxidants, serum, essential oils derived from plants, nanoparticles and others, 
are also used in sperm freezing procedures.
3. Conditions requiring sperm preservation
Diversity of health conditions and personal or lifestyle circumstances could 
necessitate semen cryopreservation.
3.1 Sperm freezing for cancer patients
Five most common cancers diagnosed in men are prostate cancer, lung cancer, 
colorectal cancer, bladder cancer and melanoma. Testicular tumors, relatively rare 
condition on a per-population basis, are the most common malignancy in men aged 
20 to 35 years [9, 10]. According to The National Cancer Institute one in two men will 




1.8% decrease in cancer death for male patients was recently published [11]. Modern 
medicine and constant scientific research in the field are the key to increasing the 
chances for long term survival (5 and above years). Quality of life after cancer treat-
ment and when in remission is of great importance. Unfortunately, cancer by itself 
and chemo- and/or radiotherapy treatment, have adverse effect over the process of 
spermatogenesis. For most cured patients, after healing, sperm production recovers 
to a certain level in time. When bilateral orchiectomy was performed or high dosage 
of radiotherapy (24–25 Gy) was administrated permanent loss of fertility is inevi-
table [12]. Introducing cancer patients to fertility preservation before the treatment 
is required, especially for adolescents and young adults (aged 15–39 years) [13].
3.2 Sperm freezing for patients with retrograde ejaculation and hypospermia
Ejaculatory disorders could lead not only to psychological distress but may be 
the reason for 0.2–3% of infertility incidence in the couple. Co-ordination between 
epididymis, vas deferens, prostate, seminal vesicles, bladder neck and bulboure-
thral glands is required for the proper course of ejaculation. Various pharmacologi-
cal, neurogenic or anatomic factors, disrupting the contraction of the bladder neck, 
may lead to retrograde ejaculation. In such cases semen is refluxed in the bladder 
and blends with the urine [14, 15]. As the urine normally has slightly acidic pH lev-
els (average value - 6.0) compared to pH 7.1–8.0 of semen, the fusion of these fluids 
and pH fluctuations has adverse effect on spermatozoa [16]. Sperm cells retrieved 
from postejaculatory urine could be proceeded for assisted reproduction. Strict 
protocols for urine alkalization prior the procedure are mandatory. In some patients 
retrograde ejaculation results in hypospermia (abnormally low volume of less 
than 1.5 ml of the semen sample). Congenital absence of seminal vesicles and vas 
deferens, blockage of the ejaculatory duct, sympathetic nerves damage, and bladder 
neck surgery, insufficient levels of testosterone and short abstinence periods could 
also be the reason for hypospermia.
Retrograde ejaculation and hypospermia are linked to poor sperm parameters even 
cryptozoospermia. Freezing spermatozoa for fertility preservation in order to secure 
ART procedure would benefit any patient diagnosed with the described conditions.
3.3 Sperm freezing for patients with diabetes
Diabetes, a chronic autoimmune disease, is known to have detrimental effect 
to male fertility and sperm quality. Erectile dysfunction, retarded ejaculation and 
retrograde ejaculation could be persistent in patients with diabetes type 1 or 2. 
Reduced sperm quality and sperm DNA integrity impairment are also consequences 
to this health condition [17]. As all of the aforementioned are to affect fertility, 
cryopreservation of spermatozoa should be considered.
3.4 Sperm freezing for patients with Y-microdeletion and genetic aberrations
Alterations in autosomal genes, specific mutations/deletions of several X- or 
Y-chromosome genes, microdeletions in the azoospermic factor (AZF) regions of 
the Y chromosome and chromosomal anomalies can cause spermatogenic failure 
and affect male fertility.
Aberration in numerous autosomal genes result in fertility disturbance:
SYCP3 (synaptonemal complex protein 3) - meiotic arrest and consequent 
azoospermia.
PLK4 (Polo-like kinase 4) – Sertoli cell only (SCO) syndrome.
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NANOS1 (Nanos C2HC-Type Zinc Finger 1) – SCO syndrome and 
oligoasthenoteratozoospermia.
HSF2 (heat-shock factor protein 2) - idiopathic azoospermia.
TAF4B (TATA-Box Binding Protein Associated Factor 4b) - azoospermia.
ZMYND15 (Zinc Finger MYND-Type Containing 15) - azoospermia.
SPATA16 (Spermatogenesis-associated protein 16) – globozoospermia.
KHLH10 (Kelch Like Family Member 10) – oligozoospermia.
SEPT12 (septin 12) - oligoasthenozoospermia or asthenoteratozoospermia.
GALNTL5 (Polypeptide N-Acetylgalactosaminyltransferase Like 5) –  
asthenozoospermia.
AURKC (Aurora Kinase C) - large-headed polyploid spermatozoa or 
macrozoospermia.
Alterations in X-chromosome located genes and fertility disturbance:
TEX11 (Testis Expressed 11) - meiotic arrest and consequent azoospermia.
RHOXF1 and RHOXF2/2B (human reproductive homeobox (RHOX) genes) - 
severe oligozoospermia.
ANOS1 (Anosmin 1) - anosmin-1 is involved in the migration of neurons 
producing gonadotropin-releasing hormone (GnRH). The latter controls the 
production of several hormones triggered to sexual development before birth and at 
puberty.
USP26 (deubiquitinating enzyme gene) - nucleotide variations in fertile and 
infertile men.
TAF7L (TATA-box binding protein associated factor 7) – reduced sperm count 
and motility, abnormal sperm morphology [18–20].
Y-microdeletion and fertility:
Y-chromosome microdeletions (YCMs) are the most common known structural 
chromosomal abnormalities for spermatogenic impairment. As high as 25–55% of 
the patients with hypospermia, sperm maturation arrest and SCO syndrome and 
5–25% of the patients with severe oligozoospermia or azoospermia are established 
to have YCMs [21].
Deletions occur in three specific subregion - AZFa, AZFb and AZFc of the AZF 
in the long arm of the Y chromosome. Deletions in these regions are associated  
with:
AZFa region partial removal - hypo-spermatogenesis.
AZFa region complete deletion - inhibits the production and maturation of germ 
cells; SCO syndrome.
AZFb region deletions - pre-meiotic spermatogenic arrest or SCO syndrome; 
azoospermia, oligozoospermia.
AZFc region partial deletions - hypospermatogenesis.
AZFc region complete deletion - SCO syndrome and alterations in spermatocyte 
maturation [22].
Different studies indicate highest incidence of Y-microdeletion in the AZFc 
region, followed by AZFa+b + c; AZFb+c; AZFb; AZFa; and partial AZFa region 
deletion [23–25].
Passing genetic impairment to the offspring should be of high caution when 
sperm freezing and consequent ART is discussed.
3.5  Sperm freezing for patients with severe oligoasthenoteratozoospermia 
(OAT) or cryptozoospermia
Cryptozoospermia or virtual azoospermia and severe OAT may be the conse-




occur for hormonal reasons, injuries, infections, varicocele, genetic abnormalities 
and improper descent of the testicle into the scrotum in newborn and infants. 
Lifestyle, occupational and environment factors have been proven to show 
adverse influence over male fertility. Obesity, alcohol consumption in regular 
and high potions, sedentary lifestyle are among the factors with high impact over 
semen parameters. As a prominent part of today’s mode of life, stress should not 
be underestimated as it negatively affects male fertility. Occupational exposure 
to pesticides, chemicals, hormones, regular intake of enhancing drugs or thera-
peutic drug treatment may have an influence on the highly sensitive process of 
spermatogenesis. Environment radiation, tocsins, air and water pollution, phthal-
ates, etc. are also linked to decrease in sperm count and motility as they may alter 
spermatogenesis [26–29].
In all groups under risk of infertility due to any of the preceding factors, freezing 
several sperm samples should be considered as a safety pool [30].
4. Sperm freezing protocols and efficiency
There are two main protocols for sperm freezing:
4.1 Slow freezing
The protocol for slow freezing of spermatozoa was suggested by Behram and 
Salewa in 1966 [31]. It is based on slow dehydration of the cells. Slow freezing could 
be performed either manually or by using programmed freezer. The sperm samples 
are cooled in a stepwise manner by lowering the temperature and adding cryopro-
tectants. Initially the temperature is lowered by 0.5°C/min and it should go down 
from room temperature to +5°C. The second step is to freeze the samples from +5°C 
to −80°C by lowering the temperature by 1–10°C/min. Finally the semen samples 
are transferred into liquid nitrogen (LN2) at −196°C.
Automatic freezers have been reported as reliable when freezing sperm is per-
formed. One of the advantages of these devices is the perfect control over tempera-
ture changes as the process is performed through software. The three step protocol 
of slow freezing takes about 40 min [32].
In slow freezing, changes in lipid phase transition and increase in lipid peroxida-
tion, consequent to saturation with cryoprotectants, could cause intracellular and 
extracellular physical and/or chemical damage to sperm membranes. Susceptible 
to cryopreservation induced damage are the viability, motility and the morphology 
of the post-thawed spermatozoa. Mitochondrial function, as well as DNA integrity, 
could be affected [33–36].
4.2 Rapid freezing: vitrification
Vitrification, as a method for cryopreservation, has been primarily used for 
cryobanking of oocytes and embryos. This method is based on direct exposure of 
the gametes to liquid nitrogen at −196°C. In comparison to slow freezing, where 
formation of intracytoplasmic ice crystals could damage different cell structures, 
during vitrification the liquid components of the cells set into a glass like amor-
phous solid and ice crystal structures are avoided (Figure 1) [37].
Regardless the protocol used for cryopreservation of spermatozoa, cryoprotec-
tive medium must be inset in order to reduce the stress induced while freezing or 
thawing cells.
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Permeable cryoprotectants can penetrate through cell membranes. They have 
intra- and extracellular activity. By forming osmotic gradient, water is ejected 
outside the cell, preventing it to form crystals. The cryoprotecting agents forms 
non-frozen channels in the medium in which sperm cells can be positioned while 
frozen. Glycerol, ethylene glycol, dimethyl sulfoxide (DMSO) and 1, 2 propanediol 
(PROH) are commonly used permeable cryoprotectants.
Non-permeable cryoprotectants cannot penetrate through the cell membrane. 
They can induce dehydration of the cells by increasing the concentration of extra-
cellular solutes. Osmotic gradient is formed and the intracellular water is derived. 
Various sugars (raffinose, mannose, and trehalose) and proteins (lipoprotein, egg 
yolk) can be inset as Non-permeable cryoprotectants [38, 39].
5. Rare sperm freezing
Rare sperm freezing could be defined as a separate branch in sperm cryobiology. 
It has formed an important direction in the development of freezing protocols, 
methods and devices. The need for efficient freezing protocol for single sperm cells 
was evident at the very beginning, when pregnancies from epididymal and testicu-
lar sperm were reported [40–42]. In cases, where percutaneous epididymal aspira-
tion (PESA) or testicular sperm extraction (TESE) is performed, freezing sperm 
cells would be of great benefit to the patient, as these procedures are traumatic and 
stressful to the organism. Most of the conditions described at 3. Conditions requir-
ing sperm preservation and poor semen quality are to request freezing of sporadic 
sperm cells.
Rare sperm freezing has some major advantages to standard protocols. In 
one hand this method gives chances for reliable fertility preservation in patient 
with severe male factor and sperm alterations. On the other hand, the successful 
freezing of single sperm cells and revolutionary methods such as intracyto-
plasmic sperm injection (ICSI), represent the opportunity for storage of larger 
quantity of samples for every men, as this premise increases the chances for 
fertilization of more oocytes retrieved in a cycle or secures larger number of 
ART cycles.
Figure 1. 




6. Rare sperm freezing protocols, carriers and devices
6.1 Biological carriers for rare sperm cryopreservation
6.1.1 Evacuated zona pellucida
Cryopreservation of single sperm cells in empty zona pellucida (ZP) was ini-
tially described in 1997 [43]. The biological carrier could be obtained by mouse or 
hamster pre-fertilization oocytes, human immature oocytes (e.g. germinal vesicle 
stage) prior fertilization, or embryos with abnormal fertilization and development 
after ICSI. The cumulus oophorus was removed via hyaluronidase and corona radi-
ate was stripped by micropipettes. The oocyte was fixed with the holding pipette 
of the ICSI micromanipulator. By applying mechanical breach, chemical reagents 
(acidified Tyrode’s solution) or highly focused laser beam, two small holes in the ZP 
were perforated. The cytoplasm of the oocyte must be aspirated and fully removed 
leaving the ZP empty of contents.
Sperm cells were obtained by centrifugation and placed in a droplet of 10% 
polyvinylpyrrolidone (PVP) solution. Using the ICSI needle each empty zona was 
injected with one to fifteen sperm cells. Slow freezing protocol and cryoprotective 
media of 8% glycerol solution in phosphate-buffered saline (PBS) and human 
serum albumin (3%) were preferred. The empty zonas were transfered in an indi-
vidual sterile plastic straws of 0.25 ml. For easy location of their position they were 
situated between two small air bubbles.
Thawing of the biological carrier was implemented through exposure of the 
plastic straws to 30°C for 30 seconds in water bath. The content between the two air 
bubbles was extruded into droplets medium.
There are number of studies indicating that empty zona pellucida is an ideal 
carrier when it comes to freezing extremely small number of spermatozoa [44, 
45]. Sperm recovery rate, compared to traditional freezing protocols, was higher, 
but motility recovery, DNA integrity and fertilization ability of sperm were similar 
in both methods [46]. From ethical point, it is important also to have an access to 
donated immature human oocytes and proper informed consent should be obtained 
(Figure 2).
Although this method shows high efficiency it is quite time and cost consuming 
and requires great precision with micromanipulation techniques and experience of 
the embryologist.
Figure 2. 
Spermatozoa freezing in empty zona pellucida.
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6.1.2 Volvox globator algae
Volvox gobator, a species of green algae of the genus Volvox, was described as a 
biological carrier for single sperm freezing and storage in 2004 [47]. The technique 
for loading rare sperm cells into the spherical algae is similar to the one used when 
freezing in ZP. Spermatozoa were injected in Volvox globator algae on a set of petri 
dish with media microdroplets and ICSI micromanipulator. In the pilot study, 
each Volvox sphere was loaded with eight male gametes. Cryoprotecting media 
containing 0.4% human serum albumin was supplemented. Each algae containing 
sperm was placed in a 0.2 mL plastic straw between two small air bubbles for easier 
location. Standard slow freezing protocol: 10 minutes at 4°C followed by 10 minutes 
of LN2 vapor and consequent submerging in LN2, was preferred.
Thawing of the biological carrier was performed through heating the plastic 
straws in a water bath at 25°C for 20 seconds. The content between the two air 
bubbles was extruded into droplets of medium. Sperm cells were subtracted 
through soft suction with the injection pipette at the micromanipulator set. The 
reported recovery rate (100%) and motility rate (at least 60%) were quite promis-
ing, but this method rises certain concerns. According to The United States Food 
and Drug Administration (FDA) and the European Tissue Directive regulations, 
there is no clear evidence that genetic material from the algae is not transferred and 
introduced into the oocyte with the injected sperm.
For the time being the use of non-human biological carrier in a clinical setting 
seems unacceptable. Still, there are countries with strict regulations prohibiting 
the destructive use of oocytes, and Volvox globator algae could be considered as an 
option for biological carrier when single sperm cryopreservation is nessesary [48].
Recently, non-biological carriers for rare sperm freezing, analogical to ZP and 
Volvox globator algae, were developed. Microcapsules composed of alginic acid, 
agarose or hollow hyaluronan -phenolic hydroxyl (HA-Ph) were tested with load-
ing, freezing and thawing techniques adopted from the abovementioned biological 
carriers. First attempts were conducted in 2006, when sperm cells were frozen 
in polymerized alginic acid drops [49]. Although alginate is a non-toxic polysac-
charide, the reported sperm motility after thawing was 20% lower compared to 
standard protocols. According to the study, decreased motility might be based on 
the adhesion of alginic acid to sperms surface.
Inactive and biologically sterile empty agarose microspheres of 100-μm in 
diameter were examined as carrier for the cryopreservation of one to ten sperm 
cells. The conducted post-thaw results in different studies show high recovery and 
motility rate (above 90% and above 80% respectively) and preserved membrane 
integrity of the cells [50, 51]. The hollow-core agarose capsule seems to be a promis-
ing substitute to ZP and Volvox globator algae.
Enzymatically fabricated hyaluronan (HA) microcapsules with thick membrane 
(30-μm) and 200 μm in diameter were also tested as carriers for cryopreservation of 
solitary spermatozoa. No differences according to recovery and motility rates after 
thawing of spermatozoa loaded into HA-Ph - microcapsules and ZP (95.5 vs. 93.9% 
and 13.6 vs. 15.1% respectively) were registered [48, 52].
Newly developed spherical analogues for rare sperm freezing would be of great 
benefit when ethical problems arise, and empty ZP could not be used for clinical or 
experimental application. No preliminary processing of the carrier is required and 
the procedure is less time consuming, but still highly qualified and trained embry-
ologist as well as specialized technique is needed.
The inculcation of such promising non-biologically derived carriers in cryo-





6.2 Non- biological carriers for rare sperm cryopreservation
6.2.1 Open-pulled straws
Open pulled straw (OPS) is a specially designed carrier for ultra-rapid vitrifica-
tion. The tool was introduced in 1998 by Professor Gábor Vajta and it is considered 
to be highly efficient for single sperm cryopreservation. At considerably low risk of 
microbial contamination while in LN2, OPS could be incorporated for cryopreser-
vation of very small volumes (1–5 μl), without the use of cryoprotectants. The 
reproductive cells are loaded in the end of the OPS by spontaneous capillary action 
when the straw is submerged into microdroplets of sperm suspension. The loaded 
straws, inserted into 90 mm straws, are hermetically closed and submerged in LN2 
[53]. Preselection and loading of the sperm cells into the OPS could be performed 
via polar body biopsy (PBB) pipette [54]. In order to thaw the sperm cells, the outer 
straw is cut and the open pulled straw is drawn out. The tip should be immediately 
plunged into microcentrifuge tube containing media.
The OPS tool is of comparable efficiency to other systems and methods when 
rare sperm cells are cryopreserved. It is relatively easy to use and allows selection of 
sperm by its morphokinetic parameters prior cryopreservation.
6.2.2 Cryoloops
Cryoloops have been explored as a rare sperm freezing tool by Schuster et al. In 
2002 [55]. Further investigation on nylon cryoloops with aspect to successful load-
ing of preselected spermatozoa and cryopreserving oligozoospermic samples and 
surgically retrieved epididymal or testicular spermatozoa was conducted [56]. The 
open cryoloop should be dipped in small droplet of sperm suspension and placed 
into cryovial. Ultra-rapid freezing by either direct submersion in LN2, or 5 min of 
exposure to liquid nitrogen vapor prior submersion was performed. Standard slow 
freezing protocol could also be applied. Vitrification in cryoloops without addi-
tional cryoprotectants was also investigated and higher sperm motility compared to 
control group with cryoprotectants was reported (89.5 ± 7.1% vs. 77.5 ± 8.9%) [36].
Sperm samples were thawed by resuspendation in media immediately after the 
cryovial was taken out of the liquid nitrogen.
Sperm motility, viability, plasma membrane and acrosome integrity were 
assessed. Certain concerns according to acrosome damage and sperm cryo-capaci-
tation after thawing have been arisen [57]. Cryo-injury is common consequence to 
different freezing protocols and cryoprotective media. When such small numbers 
of spermatozoa are frozen any structural or functional damage to the cell could be 
crucial to the overall treatment outcome.
This method would be convenient for sporadic sperm freezing due to its simplic-
ity. It also provides a set of samples that could be used in multiple ART cycles for 
ICSI procedures. Cross-contamination should be considered as the cryoloop system 
is opened and allows liquid nitrogen flow.
6.2.3 Cryopreservation in microdroplets
Ultra-rapid cryopreservation of rare sperm cells in microdroplets results in high 
post thaw total motility and progressive motility rates compared to slow freezing 
technique. Sperm DNA fragmentation index (DFI) was also comparable to stated 
values in the fresh sample. On contrary, when standard slow freezing was conducted, 
DFI values increased significantly after cryopreservation in the post-thawed samples 
[58]. This method was adopted and resembles oocyte and embryo vitrification. 
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Suspension, obtained by the mixture of proceeded sperm and cryoprotective media 
(1: 1) added by drops in every 30 seconds, was prepared. Modified French mini 
straws, cut in half from the center to the end by its length, were loaded with 2 μl 
droplets of the suspension after it was equilibrated at room temperature for 10 min-
utes. Each hemi-straw (HS) was loaded by the extents of the open gutter with 10–15 
droplets placed at equal distance of 2 mm in-between. The HS was placed in 0,5 ml 
straw and was secured through the two-stage stoppers which it has. After short 
exposure to LN2 vapor the straws were plunged into liquid nitrogen. Droplets carry-
ing sperm cells were derived by gentle struck of the HS against the bottom of 1.5 ml 
Eppendorf tube. The samples were incubated at 37°C for 15 minutes. No additional 
centrifugation for enrichment of the sample was necessary. Washing the cryoprotec-
tive media was performed for the selected spermatozoa in droplets of the ICSI dish 
before sperm injection. This seems to be quite convenient when poor semen samples 
are frozen, as reduction of numerous centrifugation and washing steps increases the 
chance for higher number of sperm cells retrieved after thawing.
6.2.4 Cryotop
Cryotop, mainly used as embryo freezing and storage commercialized tool, 
has been adopted as a carrier for sperm vitrification. Different studies have been 
conducted in order to establish the most efficient protocol when Cryotop as a 
carrier is used. The most efficient protocol for the vitrification of rare sperm cells 
was setting 1 μl droplet of sperm suspension and sucrose as cryoprotectants on the 
strip. The Cryotop was immediately transferred over LN2 vapor (2 min at −120°C) 
and then plunged into liquid nitrogen. Reported recovery and motility rates after 
thawing sperm cells retrieved from the testes were 95% and 42.1%, and for single 
sperm cryopreservation obtained from ejaculates – 90% and 44.4% respectively 
[59]. Freezing semen samples on Cryotop and without cryoprotectants show higher 
viability after thawing and lower damage to DNA integrity compared to samples 
frozen with sucrose as adjuvant [60].
Cryotop is efficient tool for cryopreservation of embryos and rare sperm 
samples. It rises no ethical issues as it is of non-biological origin. The tool has been 
implemented in cryobiology and it has been randomly used resulting in successful 
pregnancies. In recent years, similar devices, based on knowledge cumulated from 
Cryotop examination, were developed. Moreover, due to its great performance, 
Cryotop has been used as a measure tool for newly developed sporadic sperm cells 
freezing devices and their efficiency [61].
6.2.5 Cell sleeper
Freezing small number of spermatozoa is still a challenge for modern cryobiol-
ogy. In order to find not only the most reliable and efficient, but a carrier easy to use 
and relevantly less time consuming, different devices were fabricated, tested and 
compared.
Cell sleeper is a novel device with comparatively small use in practice. It is 
constructed of an inner tray as a sperm sample carrier and an outer vial. The system 
is closed and when the tray is placed inside the vial they are sealed together by a 
screw cap [62]. The device could be used as a cryopreservation carrier for prese-
lected spermatozoa derived from ejaculates or from testicular tissue. Sperm cells 
were transferred from the proceeded samples in a microdroplet of freezing media 
on the tray of the Cell sleeper through ICSI needle. After placing the tray inside the 
vial and sealing it through the cup, the vial was positioned over LN2 vapor (2.5 min 




For thawing of the sample, the vial was warmed at room temperature for 
1 minute. Afterwards the tray was drawn out of the vial and transfered in a petri 
dish then covered with oil. Following incubation period (37°C for 2 minutes) the 
recovery and motility rates were observed. Sperm recovery and motility rates of 
94% and 56% were stated. Pregnancies were reported for both – ejaculated and 
retrieved from testicular tissue sperm cells [62, 63].
This device needs further investigation, but the comparatively large volume of 
the drop placed in the tray inevitably leads to time consuming search for the sperm 
cells. Since time for micromanipulation of the oocytes is important matter the latter 
could be considered as great disadvantage of the Cell Sleeper device.
6.2.6 Polydimethylsiloxane (PDMS) chip
Microfluidic devices for gamete handling have been incorporated in ART more 
than 20 years ago [64]. Since the initial study of the technology, the microfluidic 
systems developed specifically for sperm investigation, selection and cryopreserva-
tion, have been upgraded, improved and widely used in the clinical practice.
Polydimethylsiloxane (PDMS), silicone elastomer, chips for cryopreservation 
of single spermatozoa without cryoprotectants have been thoroughly investigated. 
Microfluidic two-layered chip was fabricated. The upper layer has two separate 
openings – inlet, transfusing into microchannel, and outlet. The smooth bot-
tom layer is connected through plasma to the upper one. Different height of the 
microchannel were examined. For ultra-rapid freezing of rare sperm cells without 
cryoprotective media, best results were obtained when 10 μm height microchannel 
was tested [65].
Before cryopreservation the ejaculate should be processed by sperm gradient 
technique. The semen sample was loaded in the microchannel of the sterilized chip 
through the inlet. Approximately 5 × 10−3 μL medium containing 1000 sperm cells 
can be injected in the 10 μm channel by needle connected to micro-injector. The 
whole chip is covered in silver paper, so direct contact with liquid nitrogen could be 
avoided.
The chip containing sperm cells was thawed at 37°C for 10 min. The content was 
ejected in a culture petri dish through the outlet by applying pressure of a syringe 
connected with the input. Sperm viability, motility, DNA and acrosome integrity 
in post-thawed samples were researched. Comparison for PDMS chips with 10 μm 
height microchannel, where samples were frozen with ultra-rapid cryoprotectants-
free protocol, and samples frozen through conventional slow freezing protocol was 
conducted. The compared post-thaw parameters for the investigated parameters 
were of comparable values. The most essential advantage of the on chip ultra-rapid 
cryoprotectants-free cryopreservation is the lack of cytotoxic cryoprotective media. 
The thawing of the sample, as no cryoprotectants were added, is simple and time 
and consumable saving [66].
6.2.7 Sperm vitrification device (sperm VD)
Sperm vitrification device (Sperm VD) is a novel tool specially designed for 
cryopreservation of small number of spermatozoa in microdroplets [67]. The 
device could be exclusively helpful when sperm cells are retrieved by means of 
TESE. Each Sperm VD plate carrier has three wells for placing sperm cells. Droplets 
of mixture 1:1 of cryoprotectants and washing media are placed individually for 
each well of the Sperm VD plate. Sperm VD should be transferred in a petri dish 
covered with oil. Using the injection needle of the micromanipulator, spermatozoa 
were transferred from neighboring droplets (PVP/washing media) into the droplets 
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of the wells of the Sperm VD. As cryoprotective media has negative influence 
on sperm cells it is crucial to minimize the time of exposure to the media before 
freezing the sperm. Substantial freezing should be done within 10 minutes past 
the first sperm cell transfer [68]. After loading each well of the Sperm VD plate it is 
transferred in pre-cooled cryotube over liquid nitrogen. The tool should be handled 
with tweezers and the excess oil should be allowed to drain. The cryotube is sealed 
with cup.
Immediately after unfreezing (5 min in room temperature) the Sperm VD is 
placed in a pre-heated petri dish with PVP drops and sperm wash media covered 
with oil.
Sperm VD is quite convenient for rare sperm freezing and it gives the opportu-
nity for direct sperm washing, selection and injection in the petri dish right after 
thawing.
7. Rare sperm freezing significance
Since the first attempts for freezing reproductive cells, a completely new horizon 
for fertility preservation has been discovered. The opportunity to cryopreserve, 
thaw and use gametes, embryos and reproductive tissue has given the unique 
chance to men and women to parent their biological child even when their repro-
ductive functions have been lost.
Modern day society has invented and incorporated countless amenities in day 
to day life. Unfortunately, some of them have direct negative impact on health: pol-
luted air as the result of factory overproduction, car exhaust gasses, overconsump-
tion and large amount of waste contaminating water and agricultural lands, etc. 
Others tend to create bad habits: sedentary way of life and lack of physical activity, 
unhealthy and excessive eating, smoking, and drinking. Mental health, self-esteem 
and tension should also be considered when certain health issues arise. All of the 
above mentioned factors, including reproduction postpone and advanced paternal 
age, could disrupt fertility. Thus cryopreservation has great value in ART.
Cancer, the scourge of modern society, could affect reproduction and leave an 
indelible mark in one’s life. Preserving fertility in cancer patients should be a prior-
ity as high as the treatment of the cancer itself – a guarantee for good quality of life 
after healing. Cancer by itself may affects fertility and alterations in spermatogen-
esis and low sperm quality could be registered even before treatment [69]. Rare 
sperm freezing of multiple samples for those patients is mandatory. The unique 
techniques developed for single sperm freezing and cryopreservation represent the 
chance for those patients to reproduce in future.
Rare sperm cryopreservation is of high value to patients with severe oligoas-
thenozoospermia, cryptozoospermia, retrograde ejaculation, and PESA or TESE 
procedures. All these conditions are associated with extremely low sperm count in 
the ejaculate and still creates difficulties for laboratory handling. Securing frozen 
samples through single sperm cryopreservation, inspires calm not only to the 
patient, but to the clinical and laboratory staff handling the gametes.
Rare sperm cryopreservation could be considered as opportunity beneficial 
to wildlife and endangered species preservation [70–72]. Breeding and assisted 
reproduction in animals has long-standing traditions and has been explored in hus-
bandry for centuries. In times when hundreds of animal species are near extinction, 
rare sperm freezing is a key procedure for stock up of larger amount of samples for 
future breeding. Genetic diversity should be preserved and on time establishment 
of cryobanks conserving samples of different representatives of the species on 





Rare sperm freezing is a procedure with wide application and of high value in 
many aspects to ART, fertility preservation and endangered wildlife conservation. 
Freezing single sperm cells is still a challenge in modern laboratories. Incredible 
effort has been set and numerous devices and sperm freezing protocols have been 
investigated in order to establish the most reliable approach to rare sperm freezing. 
Despite the great achievements in the area, scientists continue the search for better 
results.
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ART assisted reproductive technology
AZF azoospermic factor
DMSO dimethyl sulfoxide
DFI DNA fragmentation index
ICSI intracytoplasmic sperm injection
HA hyaluronan
HA-Ph hyaluronan -phenolic hydroxyl
HS hemi-straw
OPS Open pulled straw
PESA percutaneous epididymal aspiration
PDMS Polydimethylsiloxane
PROH 1, 2 propanediol
PVP polyvinylpyrrolidone
ROS reactive oxygen species
Sperm VD Sperm vitrification device
TESE testicular sperm extraction
SMF severe male factor
SCO Sertoli cell only syndrome
YCMs Y-chromosome microdeletions
ZP zona pellucida
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